0001209191-19-016478.txt : 20190305 0001209191-19-016478.hdr.sgml : 20190305 20190305162356 ACCESSION NUMBER: 0001209191-19-016478 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clayman Michael D. CENTRAL INDEX KEY: 0001597407 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 19658726 MAIL ADDRESS: STREET 1: C/O FLEXION THERAPEUTICS, INC. STREET 2: 10 MALL ROAD, SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-01 0 0001419600 Flexion Therapeutics Inc FLXN 0001597407 Clayman Michael D. C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 1 1 0 0 President and CEO Stock option (right to buy) 14.75 2019-03-01 4 A 0 360000 0.00 A 2029-02-28 Common Stock 360000 360000 D With respect to 290,000 of the shares subject to the option, 25% of such shares shall vest on the one year anniversary of January 1, 2019 (the "Vesting Commencement Date") and thereafter 1/48th of such shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all such shares shall be vested four years after the Vesting Commencement Date. With respect to 70,000 of the shares subject to the option, if the Company's 2019 revenues from ZILRETTA product sales are at least a specified amount, then 17,500 of such shares shall vest on January 1, 2020 and thereafter 1/48th of such shares shall vest each month following January 1, 2020, so that all of such shares shall be vested four years after January 1, 2019. /s/ Mark S. Levine, Attorney-in-Fact 2019-03-05